scholarly article | Q13442814 |
P2093 | author name string | Gen-You Yao | |
Xiao-Qing Chen | |||
Mao-De Lai | |||
Ji-Lin Zhou | |||
Pei-Hui Chen | |||
P2860 | cites work | A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours | Q28359544 |
Tumor markers in neuroendocrine tumors | Q34001693 | ||
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours | Q34474274 | ||
Classification of gastric neuroendocrine tumors and its clinicopathologic significance | Q36397178 | ||
Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature | Q37716893 | ||
Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995. | Q39546202 | ||
Somatostatin and the lung | Q40625448 | ||
Neuroendocrine differentiation in prostatic carcinoma: an update | Q41019553 | ||
Clinical significance of neuroendocrine carcinoma of the breast | Q43836880 | ||
Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors | Q44104432 | ||
Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature | Q47758479 | ||
Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. | Q52828506 | ||
Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. | Q53399228 | ||
A case of small cell carcinoma of the stomach | Q64050396 | ||
Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parameters | Q67536840 | ||
Neuroendocrine carcinoid tumours of the breast: A variant of carcinoma with neuroendocrine differentiation | Q67680724 | ||
Spindle-Cell Argyrophilic Mucin-Producing Carcinoma of the Breast Histological, Ultrastructural, and Immunohistochemical Studies of Two Cases | Q67693009 | ||
Neuro-endocrine type of gastric carcinoma. Immunohistochemical and electron microscopic studies of 100 cases | Q68157661 | ||
Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells | Q68332880 | ||
Radiosensitivity related to neuroendocrine and endodermal differentiation in lung carcinoma lines | Q69048742 | ||
Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases | Q69222280 | ||
In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogue | Q69919083 | ||
Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour | Q70390673 | ||
Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumors | Q71975836 | ||
Neuroendocrine-like differentiation in patients with pancreatic carcinoma | Q73370155 | ||
[Gastric neuroendocrine tumor] | Q74588079 | ||
Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies | Q77102007 | ||
Evaluation of chromogranin A expression in serum and tissues of breast cancer patients | Q77577181 | ||
Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor | Q77631689 | ||
Studies on the DNA content of breast carcinoma cells with neuroendocrine differentiation | Q77899862 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
P304 | page(s) | 858-861 | |
P577 | publication date | 2003-04-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases | |
P478 | volume | 9 |
Q36938703 | A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups |
Q37149103 | ACTH-Producing Breast Cancer: A Patient Report |
Q38905385 | Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer |
Q34975445 | Clonality analysis of neuroendocrine cells in gastric adenocarcinoma |
Q33195833 | Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines |
Q36502545 | Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro |
Q36603956 | Genes involved in neuroendocrine tumor biology |
Q43093716 | Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin |
Q51838966 | Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation. |
Q33908612 | Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer |
Q26778012 | Neuroendocrine differentiation: The mysterious fellow of colorectal cancer |
Q47404152 | Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction |
Q64917588 | Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality? |
Q35613016 | Pancreatic cancer - a continuing challenge in oncology |
Q64071231 | Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases |
Q38189266 | Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis |
Q81408260 | Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications |
Q83878452 | [Mixed endocrine tumors] |
Search more.